CORDIS · 608979 · FP7
ROBO-MATE Intelligent exoskeleton based on human-robot interaction for manipulation of heavy goods in Europe’s factories of the future
Coordinator: ZURCHER HOCHSCHULE FUR ANGEWANDTE WISSENSCHAFTEN (CH)
Workplace injuries cost European societies up to 4% of GNP. Over 25% of Europeans experience back injury due to work. Robots are traditionally inflexible to use for many manual handling tasks. The world robotics market is set to double to $66Bn pa in the next 15 years. Europe could corner the industrial collaborative human-robotic part of that market (currently Asia). The goal of Robo-Mate is to apply an industry focus in developing a user-friendly intelligent cooperative light weight wearable human-robotic exoskeleton for manual handling work. It will be deployable within half a day and will…
About Seventh Framework Programme (2007–2013)
The Seventh Framework Programme (FP7) ran from 2007 to 2013 and was the EU's main research-funding instrument of that period. It mobilised roughly €50 billion across cooperation projects, ERC frontier grants, Marie Curie fellowships, capacity-building actions and Euratom research. FP7 closed to new calls in 2013 but its projects continued for years after under their original grant agreements.
Co-funding: the European Union contributes €4.4M toward a total project budget of €6.0M — a funding rate of 74%, with the remainder covered by the consortium partners. The project runs over approximately 3.2 years from 2013-09-01 to 2016-11-30.
Full record on CORDIS — partners, deliverables, publications, news.
Open on cordis.europa.eu →More from CH
see all →- HBP SGA1 — Human Brain Project Specific Grant Agreement 1720270 · H2020 · €89.0M
- HBP SGA2 — Human Brain Project Specific Grant Agreement 2785907 · H2020 · €88.0M
- ATTRACT2 — Breakthrough Innovation Programme for a Pan-European Detection and Imaging Eco-System – Phase-2101004462 · H2020 · €35.0M
- STEMBANCC — Stem cells for Biological Assays of Novel drugs and prediCtive toxiCology (StemBANCC)115439 · FP7 · €26.0M
- IABC PROGRAMME — iABC Programme115721 · FP7 · €24.3M
- ULTRA-DD — Unrestricted Leveraging of Targets for Research Advancement and Drug Discovery115766 · FP7 · €21.2M
Other FP7 projects
see all →- COST II — Provision of Scientific, Technical and Administrative Management of COST200443 · FR · €250.0M
- COMBACTE-NET — Combatting Bacterial Resistance in Europe115523 · SE · €109.4M
- EUC²LID — European Lead Factory115489 · DE · €80.0M
- COMBACTE-MAGNET — Combatting Bacterial Resistance in Europe - Molecules against Gram Negative Infections115737 · SE · €75.3M
- ENABLE — European Gram Negative Antibacterial Engine115583 · UK · €58.9M
- PLACES2BE — Pilot Lines for Advanced CMOS EmbodimentS in 2x nodes, Built in Europe325633 · FR · €52.6M
Frequently asked questions
- Who funds this research project?
- This project is funded by the European Union through the Seventh Framework Programme (2007–2013) programme, under the CP-IP funding scheme.
- What is the EU contribution?
- The European Commission contributes €4.4M toward a total project budget of €6.0M.
- Which EU programme funds it?
- The project is funded under Seventh Framework Programme (2007–2013).
- Who coordinates the project?
- The project is coordinated by ZURCHER HOCHSCHULE FUR ANGEWANDTE WISSENSCHAFTEN (CH).
- What is the project timeline?
- The project runs from 2013-09-01 to 2016-11-30 — approximately 3.2 years.
- Where can I find the full project record?
- The complete record — partners, deliverables, publications and news — is published on CORDIS under project ID 608979.